Shares of UnitedHealth Group Incorporated (NYSE:UNH) have earned a consensus rating of “Buy” from the twenty-seven brokerages that are covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and twenty-four have issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $224.13.
Several analysts recently commented on the stock. ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Raymond James Financial reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 6th. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Finally, Oppenheimer raised their price objective on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th.
In other news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the sale, the director now directly owns 61,137 shares in the company, valued at $13,652,503.47. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Insiders have sold a total of 62,606 shares of company stock valued at $12,677,525 over the last 90 days. 0.89% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently modified their holdings of UNH. Blue Chip Partners Inc. purchased a new stake in shares of UnitedHealth Group during the second quarter worth about $110,000. Kings Point Capital Management grew its holdings in UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after purchasing an additional 150 shares during the period. Bruderman Asset Management LLC purchased a new stake in UnitedHealth Group in the second quarter valued at approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its holdings in UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the period. Finally, BDO Wealth Advisors LLC purchased a new stake in UnitedHealth Group in the second quarter valued at approximately $121,000. Institutional investors and hedge funds own 86.20% of the company’s stock.
Shares of UnitedHealth Group (NYSE:UNH) traded up $1.86 during midday trading on Thursday, hitting $224.35. 3,059,400 shares of the company traded hands, compared to its average volume of 3,100,568. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group has a 12-month low of $156.09 and a 12-month high of $231.77. The firm has a market capitalization of $216,240.00, a PE ratio of 23.17, a price-to-earnings-growth ratio of 1.65 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter last year, the business earned $2.17 earnings per share. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. research analysts forecast that UnitedHealth Group will post 9.99 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st were issued a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.34%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.09%.
COPYRIGHT VIOLATION NOTICE: This piece of content was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://ledgergazette.com/2017/12/14/unitedhealth-group-incorporated-unh-given-consensus-rating-of-buy-by-analysts.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.